Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07437508 · ClinicalTrials.gov registry record
Pharmacy Transitional Team: Evaluating the Value for Patients With Limited English Proficiency
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 17
- Enrollment target
NCT07437508: Completed study, sponsored by University of Washington.
NCT07437508 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07437508 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The overall goal of this proposed study is to characterize the experiences, barriers and facilitators related to providing effective care transitions from hospital to post-acute care settings to elucidate the failures that drive disparate outcomes using qualitative methodology and to ultimately adapt standardized processes to close the equity gap.
Primary Outcome
The primary outcome is the set of qualitative themes identified through inductive content analysis of semi-structured interview transcripts. Interview transcripts will be coded using a structured codebook, and emergent themes related to communication, language needs, barriers, facilitators, and care transition experiences will be identified and categorized.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2025-06-30 |
What the finished NCT07437508 record still lists
NCT07437508 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07437508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07437508 about?
NCT07437508 is a clinical study titled "Pharmacy Transitional Team: Evaluating the Value for Patients With Limited English Proficiency". The overall goal of this proposed study is to characterize the experiences, barriers and facilitators related to providing effective care transitions from hospital to post-acute care settings to elucidate the failures that drive disparate outcomes using qualitative methodology and to ultimately adap...
What is the current status of trial NCT07437508?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2023-07-12. Estimated completion is 2025-06-30.
Who is sponsoring clinical trial NCT07437508?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI